Investors focused on the Medical space have likely heard of Sunesis Pharmaceuticals (SNSS), but is the stock performing well in comparison to the rest of its sector peers? One simple way to answer ...

While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, virus news and stimulus talks, many smart money investors are starting to get ...

As of late, it has definitely been a great time to be an investor in Sunesis Pharmaceuticals, Inc. ( SNSS). The stock has moved higher by 9.1% in the past month, while it is also above its 20 Day SMA ...

SOUTH SAN FRANCISCO, Calif., July 13 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS - News), a biopharmaceutical company focused on the ...

FORT LEONARD WOOD, Mo. — Social networking sites, or SNSs for short, are great ways to connect with people, share information and market products and services. However, they can also provide ...

Sunesis Pharmaceuticals, Inc. ( SNSS) has been on the move lately as the stock has risen by 27.6% in the past four weeks, and it is currently trading well above its 20-Day SMA. This is a pretty solid ...

Due to the fact that Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) has experienced falling interest from the smart money, we can see that there lies a certain “tier” of fund managers that elected to cut ...